105 related articles for article (PubMed ID: 23047898)
21. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
[TBL] [Abstract][Full Text] [Related]
22. ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness.
Peng Y; Chen Z; Chen Y; Li S; Jiang Y; Yang H; Wu C; You F; Zheng C; Zhu J; Tan Y; Qin X; Liu Y
Acta Biomater; 2019 Apr; 88():86-101. PubMed ID: 30771534
[TBL] [Abstract][Full Text] [Related]
23. BCR/ABL induces multiple abnormalities of cytoskeletal function.
Salgia R; Li JL; Ewaniuk DS; Pear W; Pisick E; Burky SA; Ernst T; Sattler M; Chen LB; Griffin JD
J Clin Invest; 1997 Jul; 100(1):46-57. PubMed ID: 9202056
[TBL] [Abstract][Full Text] [Related]
24. Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK.
Hickey FB; England K; Cotter TG
J Leukoc Biol; 2005 Jul; 78(1):289-300. PubMed ID: 15857938
[TBL] [Abstract][Full Text] [Related]
25. p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr.
Korus M; Mahon GM; Cheng L; Whitehead IP
Oncogene; 2002 Jul; 21(30):4601-12. PubMed ID: 12096337
[TBL] [Abstract][Full Text] [Related]
26. P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation.
Wilson-Rawls J; Xie S; Liu J; Laneuville P; Arlinghaus RB
Cancer Res; 1996 Aug; 56(15):3426-30. PubMed ID: 8758906
[TBL] [Abstract][Full Text] [Related]
27. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
28. Purification of TAT-CC-HA protein under native condition, and its transduction analysis and biological effects on BCR-ABL positive cells.
Huang Z; Ji M; Peng Z; Huang S; Xiao Q; Li C; Zeng J; Gao M; Feng W
Biomed Pharmacother; 2011 Jun; 65(3):183-92. PubMed ID: 21641753
[TBL] [Abstract][Full Text] [Related]
29. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line.
Carlesso N; Griffin JD; Druker BJ
Oncogene; 1994 Jan; 9(1):149-56. PubMed ID: 8302574
[TBL] [Abstract][Full Text] [Related]
30. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
[TBL] [Abstract][Full Text] [Related]
31. Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571.
Mazzacurati L; Pattacini L; Brusa G; Mancini M; Benvenuti M; Barbieri E; Martinelli G; Baccarani M; Greenberger JS; Santucci MA
Hematol J; 2004; 5(2):168-77. PubMed ID: 15048068
[TBL] [Abstract][Full Text] [Related]
32. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
Lionberger JM; Smithgall TE
Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
[TBL] [Abstract][Full Text] [Related]
33. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells.
Li QF; Huang WR; Duan HF; Wang H; Wu CT; Wang LS
Oncogene; 2007 Dec; 26(57):7904-8. PubMed ID: 17599053
[TBL] [Abstract][Full Text] [Related]
35. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
36. Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells.
Estornes Y; Gay F; Gevrey JC; Navoizat S; Nejjari M; Scoazec JY; Chayvialle JA; Saurin JC; Abello J
Int J Cancer; 2007 Nov; 121(10):2162-71. PubMed ID: 17583572
[TBL] [Abstract][Full Text] [Related]
37. Baculovirus expression of functional P210 BCR-ABL oncogene product.
Pendergast AM; Clark R; Kawasaki ES; McCormick FP; Witte ON
Oncogene; 1989 Jun; 4(6):759-66. PubMed ID: 2499863
[TBL] [Abstract][Full Text] [Related]
38. BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cells.
Jongen-Lavrencic M; Salesse S; Delwel R; Verfaillie CM
Leukemia; 2005 Mar; 19(3):373-80. PubMed ID: 15674360
[TBL] [Abstract][Full Text] [Related]
39. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Shuai K; Halpern J; ten Hoeve J; Rao X; Sawyers CL
Oncogene; 1996 Jul; 13(2):247-54. PubMed ID: 8710363
[TBL] [Abstract][Full Text] [Related]
40. Potential role of bcr-abl in the activation of JAK1 kinase.
Henderson YC; Guo XY; Greenberger J; Deisseroth AB
Clin Cancer Res; 1997 Feb; 3(2):145-9. PubMed ID: 9815665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
